← Back to Search

Behavioral Intervention

STAIR-NT for PTSD and Substance Abuse

N/A
Waitlist Available
Led By Amanda Bunting
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 3
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to adapt a PTSD intervention for individuals with stimulant-opioid polysubstance use. The intervention will be integrated into a methadone maintenance treatment program in New York City. The

Who is the study for?
This trial is for individuals in New York City who are undergoing methadone maintenance treatment and also use stimulants and opioids. Participants should have PTSD and be willing to try a new therapy schedule. The study excludes those not meeting these specific conditions or unable to follow the trial protocol.
What is being tested?
The trial tests an adapted version of STAIR-NT, a PTSD intervention, integrated into a methadone program for people with polysubstance use. It compares the effectiveness of this new approach against the usual treatment methods over several months.
What are the potential side effects?
Since STAIR-NT is a form of therapy rather than medication, side effects may include emotional discomfort or distress due to discussing traumatic experiences but typically do not involve physical symptoms.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 3
This trial's timeline: 3 weeks for screening, Varies for treatment, and month 3 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Clinician-Rated Feasibility of Acceptability of Intervention Measure (AIM) Score
Clinician-Rated Feasibility of Intervention Measure (FIM) Score
Inventory of Interpersonal Problems Score
+6 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Adapted STAIR-NT InterventionExperimental Treatment1 Intervention
Group II: Treatment as Usual (TAU)Active Control1 Intervention

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,415 Previous Clinical Trials
855,997 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,607 Previous Clinical Trials
3,329,735 Total Patients Enrolled
Amanda BuntingPrincipal InvestigatorNYU Langone Health
~50 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top